Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
ANI ‘On The Cusp Of A Transformation’ Following Cortrophin Launch
Company Expects Up To $40m From The Product In 2022
May 19 2022
•
By
Chloe Kent
ANI's share price took a hit following losses related to commercial expenses. • Source: Shutterstock
More from Earnings
More from Business